Literature DB >> 32604413

Community-acquired Coinfection in Coronavirus Disease 2019: A Retrospective Observational Experience.

Christopher J Lehmann1, Mai T Pho1, David Pitrak1, Jessica P Ridgway1, Natasha N Pettit2.   

Abstract

Community-acquired coinfection in coronavirus disease 2019 (COVID-19) is not well defined. Current literature describes coinfection in 0-40% of COVID-19 patients. In this retrospective report, coinfection was identified in 3.7% of patients and 41% of patients admitted to intensive care (P < .005). Despite infrequent coinfection, antibiotics were used in 69% of patients.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; antibiotics; coinfection; superinfection

Year:  2021        PMID： 32604413      PMCID： PMC7337635          DOI： 10.1093/cid/ciaa902

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  14 in total

Review 1.  Empiric Antibiotics in COVID 19: A Narrative Review.

Authors:  Elvina C Lingas
Journal:  Cureus       Date:  2022-06-02

2.  Impact of an Antimicrobial Stewardship Intervention on Usage of Antibiotics in Coronavirus Disease-2019 at a Tertiary Care Teaching Hospital in India.

Authors:  Kalyani Borde; Mahender Kumar Medisetty; Baby Shalini Muppala; Aishwarya B Reddy; Sireesha Nosina; Manick S Dass; A Prashanthi; Pushpanjali Billuri; Dilip Mathai
Journal:  IJID Reg       Date:  2022-02-07

Review 3.  Microbiologically confirmed infections and antibiotic-resistance in a national surveillance study of hospitalised patients who died with COVID-19, Italy 2020-2021.

Authors:  Marco Floridia; Marina Giuliano; Monica Monaco; Luigi Palmieri; Cinzia Lo Noce; Anna Teresa Palamara; Annalisa Pantosti; Silvio Brusaferro; Graziano Onder
Journal:  Antimicrob Resist Infect Control       Date:  2022-05-21       Impact factor: 6.454

4.  Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis.

Authors:  Jackson S Musuuza; Lauren Watson; Vishala Parmasad; Nathan Putman-Buehler; Leslie Christensen; Nasia Safdar
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

Review 5.  The Complexity of Co-Infections in the Era of COVID-19.

Authors:  Nevio Cimolai
Journal:  SN Compr Clin Med       Date:  2021-04-23

Review 6.  Microbial co-infections in COVID-19: Associated microbiota and underlying mechanisms of pathogenesis.

Authors:  M Nazmul Hoque; Salma Akter; Israt Dilruba Mishu; M Rafiul Islam; M Shaminur Rahman; Masuda Akhter; Israt Islam; Mehedi Mahmudul Hasan; Md Mizanur Rahaman; Munawar Sultana; Tofazzal Islam; M Anwar Hossain
Journal:  Microb Pathog       Date:  2021-05-04       Impact factor: 3.738

7.  SARS-CoV-2 and Streptococcus pneumoniae Coinfection in a Previously Healthy Child.

Authors:  Kimberly C Vu; Gloria P Heresi; Michael L Chang
Journal:  Case Rep Pediatr       Date:  2021-12-08

8.  Bacterial co-infection at hospital admission in patients with COVID-19.

Authors:  Estela Moreno-García; Pedro Puerta-Alcalde; Laura Letona; Fernanda Meira; Gerard Dueñas; Mariana Chumbita; Nicole Garcia-Pouton; Patricia Monzó; Carlos Lopera; Laia Serra; Celia Cardozo; Marta Hernandez-Meneses; Verónica Rico; Marta Bodro; Laura Morata; Mariana Fernandez-Pittol; Ignacio Grafia; Pedro Castro; Josep Mensa; José Antonio Martínez; Gemma Sanjuan; Mª Angeles Marcos; Alex Soriano; Carolina Garcia-Vidal
Journal:  Int J Infect Dis       Date:  2022-03-05       Impact factor: 12.074

9.  Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic.

Authors:  Samaneh Pourajam; Elham Kalantari; Hamid Talebzadeh; Hamid Mellali; Ramin Sami; Forogh Soltaninejad; Babak Amra; Mahdi Sajadi; Malihe Alenaseri; Forough Kalantari; Hamid Solgi
Journal:  Front Cell Infect Microbiol       Date:  2022-02-23       Impact factor: 5.293

10.  The Spectrum of Antibiotic Prescribing During COVID-19 Pandemic: A Systematic Literature Review.

Authors:  Sara H Al-Hadidi; Hashim Alhussain; Hamad Abdel Hadi; Alreem Johar; Hadi M Yassine; Asmaa A Al Thani; Nahla O Eltai
Journal:  Microb Drug Resist       Date:  2021-06-01       Impact factor: 3.431
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.